https://www.selleckchem.com/products/azd9291.html
ruments. Two-step application is more efficient as it requires less time while maintaining the same diagnostic accuracy. Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It affects around 50% of postmenopausal women, reducing their general and sexual quality of life as well as the quality of their personal relationships. The aim of this clinical guide is to set out an individualized approach to the management of VVA with topical estrogens and non-hormonal preparations. Literature review and consensus of e
Like
Comment
Share
